LFG
NVO

Larson Financial Group’s Novo Nordisk NVO Stock Holding History

Larson Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
4,829
+1,183
+32% +$50.8K 0.01% 793
2026
Q1 		$134K Buy
3,646
+2,028
+125% +$96.1K ﹤0.01% 869
2025
Q4 		$82.3K Sell
1,618
-1,774
-52% -$90.7K ﹤0.01% 1000
2025
Q3 		$188K Sell
3,392
-1,187
-26% -$69.5K 0.01% 710
2025
Q2 		$316K Buy
4,579
+587
+15% +$39.9K 0.01% 555
2025
Q1 		$277K Buy
3,992
+603
+18% +$49.8K 0.01% 554
2024
Q4 		$292K Buy
3,389
+347
+11% +$37.5K 0.02% 488
2024
Q3 		$362K Buy
3,042
+842
+38% +$112K 0.02% 416
2024
Q2 		$314K Sell
2,200
-404
-16% -$53.5K 0.02% 354
2024
Q1 		$334K Buy
2,604
+440
+20% +$52.4K 0.03% 297
2023
Q4 		$224K Sell
2,164
-31
-1% -$3.07K 0.02% 331
2023
Q3 		$200K Buy
2,195
+2,099
+2,186% +$185K 0.02% 323
2023
Q2 		$7.77K Buy
96
+10
+12% +$817 ﹤0.01% 1005
2023
Q1 		$6.84K Hold
86
– – ﹤0.01% 1021
2022
Q4 		$5.82K Hold
86
– – ﹤0.01% 998
2022
Q3 		$4K Hold
86
– – ﹤0.01% 1002
2022
Q2 		$5K Buy
+86
New +$4.77K ﹤0.01% 879

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Larson Financial Group's NVO Position: Q2 2026 in Review

Larson Financial Group increased its Novo Nordisk (NVO) stake by 32% in Q2 2026, buying an estimated $50.8K and bringing the position to 4,829 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #793.

Larson Financial Group first reported a position in NVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $362K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Larson Financial Group held 4,829 shares of Novo Nordisk worth $231K as of Q2 2026.
  • Larson Financial Group bought 1,183 Novo Nordisk shares in Q2 2026, an estimated $50.8K.
  • Novo Nordisk made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #793 holding.
  • Larson Financial Group first reported a position in Novo Nordisk in Q2 2022 and has held it in 17 quarters since.
  • Larson Financial Group's Novo Nordisk position peaked at $362K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.